Form 4: Camp4 Therapeutics Director Sells Shares
Insider Transaction (Form 4)
Andrew J. Schwab, a Director of Camp4 Therapeutics Corp, sold 191,865 shares of common stock on August 19, 2026.
Summary
- Open-market sale: disposed of 45,147 Common Stock at $4.76 ($214,900) on August 19, 2026; holds 2,579,998 after (Indirect).
- Open-market sale: disposed of 114,700 Common Stock at $4.54 ($520,738) on August 20, 2026; holds 2,465,298 after (Indirect).
- Open-market sale: disposed of 32,018 Common Stock at $4.50 ($144,081) on August 21, 2026; holds 2,433,280 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $879,719 of stock on the open market.
Insider Transactions
Andrew J. Schwab — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-19 | Open-market sale | Common Stock | 45,147 | $5 | $214.9K | 2,579,998 |
| 2026-08-20 | Open-market sale | Common Stock | 114,700 | $5 | $520.7K | 2,465,298 |
| 2026-08-21 | Open-market sale | Common Stock | 32,018 | $5 | $144.1K | 2,433,280 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-19 | Open-market sale (45,147 shares) |
| 2026-08-20 | Open-market sale (114,700 shares) |
| 2026-08-21 | Open-market sale (32,018 shares) |
Keywords
insider transaction, Form 4, CAMP, Camp4 Therapeutics Corp, bearish, Andrew J. Schwab
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.